SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001047469-13-008310
Filing Date
2013-08-09
Accepted
2013-08-09 15:05:16
Documents
10
Period of Report
2013-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a2216267z10-q.htm 10-Q 524847
2 EX-31.1 a2216267zex-31_1.htm EX-31.1 8612
3 EX-31.2 a2216267zex-31_2.htm EX-31.2 8599
4 EX-32.1 a2216267zex-32_1.htm EX-32.1 9050
  Complete submission text file 0001047469-13-008310.txt   7709657

Data Files

Seq Description Document Type Size
5 EX-101.INS astx-20130630.xml EX-101.INS 511670
6 EX-101.SCH astx-20130630.xsd EX-101.SCH 82366
7 EX-101.CAL astx-20130630_cal.xml EX-101.CAL 52897
8 EX-101.DEF astx-20130630_def.xml EX-101.DEF 420850
9 EX-101.LAB astx-20130630_lab.xml EX-101.LAB 1342470
10 EX-101.PRE astx-20130630_pre.xml EX-101.PRE 692630
Mailing Address 4140 DUBLIN BLVD STE 200 DUBLIN CA 94568
Business Address 4140 DUBLIN BLVD SUITE 200 DUBLIN CA 94568 9255600100
Astex Pharmaceuticals, Inc (Filer) CIK: 0000919722 (see all company filings)

IRS No.: 911841574 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-27628 | Film No.: 131026208
SIC: 2834 Pharmaceutical Preparations